Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
University of Minnesota, Minneapolis, Minnesota.
Biol Blood Marrow Transplant. 2019 Dec;25(12):2330-2337. doi: 10.1016/j.bbmt.2019.04.012. Epub 2019 Apr 17.
The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.
造血干细胞移植(HSCT)项目的发展在大多数发展中国家可能会面临重大挑战,因为这些努力必须与其他政府医疗保健重点竞争,包括提供基本服务。尽管这可能是一个限制因素,但这些国家应通过提供财政、技术、法律、伦理和其他必要的支持,优先发展提供最先进治疗所需的专业知识,包括移植。这将有助于根据其人口的需求制定成功的方案,并通过避免其公民出国寻求治疗来节省长期成本。建立 HSCT 项目的成本和 HSCT 程序本身的成本可能是发展中国家的重大障碍。此外,特定国家内在的社会经济因素会影响 HSCT 的可及性、HSCT 的患者资格以及 HSCT 中心能力的及时利用。本报告介绍了全球血液和骨髓移植网络(Worldwide Network for Blood and Marrow Transplantation)关于建立 HSCT 项目的建议,重点是发展中国家,并确定了在资源有限的环境中提供这种专业手术的挑战和机遇。